Tech Company Financing Transactions
Magnolia Medical Technologies Funding Round
Magnolia Medical Technologies closed a $13.8 million Series B funding round on 7/13/2016. Investors included HealthQuest Capital and private investors.
Transaction Overview
Company Name
Announced On
7/13/2016
Transaction Type
Venture Equity
Amount
$13,800,000
Round
Series B
Investors
HealthQuest Capital (Lead Investor) (Garheng Kong)
Proceeds Purpose
Proceeds from the financing will be used to accelerate commercialization of Magnolia Medical's flagship product line, the SteriPath blood collection system. Funding will also support on-going development of the company's planned roadmap of devices designed to eliminate human errors that cause false positive and false negative clinical laboratory test results.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
200 W. Mercer St. 500
Seattle, WA 98119
USA
Seattle, WA 98119
USA
Phone
Website
Email Address
Overview
Magnolia Medical Technologies has recently introduced the Initial Specimen Diversion Device (ISDD), a patented, Class I device registered and listed with FDA that is indicated to reduce the frequency of blood culture contamination.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gregory Bullington
Chief Medical Officer
Richard Patton
Chief Operating Officer
Robert Gerberich
VP - Sales
Matthew Stuckert
Browse more venture capital transactions:
Prev: 7/12/2016: Avizia venture capital transaction
Next: 7/13/2016: Universal Avenue venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs